$PMCB News Update as PharmaCyte Discusses Phase 2b Clinical Trial in Pancreatic Cancer. The stock is currently trade below it's 52 week high of .10 News expected after Company released 2018 company presentation this week. https://seekingalpha.com/pr/17087549-pharmacyte-discusses-phase-2b-clinical-trial-pancreatic-cancer?source=tweet https://pbs.twimg.com/media/DY6dTc-W0AA6jMr.jpg